Komal Joshi | Investor Relations |
Rich Murray | Chief Executive Officer & President |
Beth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Neena Bitritto-Garg | JPMorgan |
Boris Peaker | Cowen |
Mike Ulz | Baird |
Debjit Chattopadhyay | H.C. Wainwright |
Nick Abbott | Wells Fargo Securities |
Steve Seedhouse | Raymond James |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request.
I will now turn the call over to your host Komal Joshi with Jounce Therapeutics.